In Law360 Coronavirus Q&A, Tara Fisher Discusses Leading Three Major Transactions in a Week

In The News
June 15, 2020

Law360 profiled partner Tara Fisher (Boston), and her success as an M&A and capital markets lawyer. The column highlights how Tara recently led three major transactions in the same week during the coronavirus pandemic.

Tara led Ropes & Gray teams that advised the lead underwriters on a $6.7 billion secondary offering of Regeneron Pharmaceuticals Inc. common stock by Paris-headquartered Sanofi SA; guided Novavax Inc. in its $167 million acquisition of Czech Republic-based Praha Vaccines, which is working on a potential vaccine for COVID-19; and counseled organ transplant therapy developer TransMedics Group Inc. on a $70 million underwritten public offering of common stock.

Tara notes that the depth and breadth of Ropes & Gray’s life sciences practice is an advantage because many transaction issues that come up are ones where the firm has decades of experience. She said that Paul Kinsella and Patrick O'Brien, who are both widely respected for their M&A, capital markets and life sciences expertise, are just two of the many partners who mentored her as an associate, and since making partner, as peers.